What Happened?
New York, NY-based MindMed Resigned Bradford Cross as Chief Technology Officer
Date of management change: December 29, 2021
New York, NY-based MindMed Resigned Bradford Cross as Chief Technology Officer
MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.
Bradford Cross is Chief Technology Officer at MindMed. Previously, Bradford held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Lee-Yow Kin, Yaknour Abe, Brown Tom, Creigthon Gregory, Schwartz Nelan, Coolidge Coleen, Brudermueller Martin, Chitarra Jacques, Deckert Chuck, Lobo Maxx, Berk David
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.